Precigen (PGEN) Non-Current Debt (2013 - 2026)
Precigen (PGEN) posted quarterly Non-Current Debt of $93.5 million for Q1 2026, little changed quarter-over-quarter from $93.2 million in Q4 2025.
Analysis
Precigen (PGEN) Non-Current Debt (2013 - 2026) Analysis & Trends
Precigen (PGEN) has reported Non-Current Debt for 12 consecutive years, with $93.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt changed N/A year-over-year to $93.5 million; the TTM figure through Mar 2026 stood at $93.5 million (changed N/A YoY), while the FY2025 annual figure was $93.2 million, changed N/A from the prior year.
- Non-Current Debt steadied at $93.5 million in Q1 2026 per PGEN's latest filing, from $93.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $201.1 million in Q1 2022 and bottomed at $43.2 million in Q4 2022.
- Historically, Non-Current Debt has averaged $120.4 million across 3 years, with a median of $93.3 million in 2025.
- On a YoY basis, Non-Current Debt climbed as much as 15.24% in 2022 and fell as far as 75.97% in 2022.
- Precigen's Non-Current Debt stood at $43.2 million in 2022, then jumped by 115.59% to $93.2 million in 2025, then increased by 0.37% to $93.5 million in 2026.
- Business Quant data shows PGEN's Non-Current Debt at $93.5 million in Q1 2026, $93.2 million in Q4 2025, and $92.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 591.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 882.16 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 8.96 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 93.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.88 Mn |
| Mar 31, 2026 | 93.52 Mn |
| Dec 31, 2025 | 93.17 Mn |
| Sep 30, 2025 | 92.89 Mn |
| Dec 31, 2022 | 43.22 Mn |
| Sep 30, 2022 | 82.07 Mn |
| Jun 30, 2022 | 198.67 Mn |
| Mar 31, 2022 | 201.47 Mn |
| Dec 31, 2021 | 179.93 Mn |
| Sep 30, 2021 | 180.17 Mn |
| Jun 30, 2021 | 177.28 Mn |
| Mar 31, 2021 | 174.52 Mn |
| Dec 31, 2020 | 171.88 Mn |
| Sep 30, 2020 | 194.22 Mn |
| Jun 30, 2020 | 223.31 Mn |
| Mar 31, 2020 | 220.62 Mn |
| Dec 31, 2019 | 217.99 Mn |
| Sep 30, 2019 | 215.47 Mn |
| Jun 30, 2019 | 212.95 Mn |
| Mar 31, 2019 | 214.57 Mn |